APP Monthly Lecture

Speaker:                 Dorothy Sipkins, M.D., Ph.D.

                                Associate Professor of Medicine

     Division of Hematologic Malignancies

          and Cellular Therapy      

                                Duke Medicine

Topic:                    Thrombosis in Hematologic Malignancies:

                                   Etiology, Prognosis and Management

Date:                          Thursday, November 12, 2015

Time:                         8:00 a.m.-9:00 a.m.

Location:                  CR 9015 North Pavilion, 9^th floor

                                    2400 Pratt Street

                                    Durham, NC  27705

Faculty (Speaker) Disclosures:  Dorothy Sipkins, M.D., Ph.D., has indicated that she has the following relationships with industry to disclose:  Principal Investigator for Glycomimetics, Inc. and Principal Investigator for Gilead Pharmaceuticals, Inc.

Activity Medical Director/Planning Committee Disclosure(s):  Dr. Nelson Chao has indicated that he has no relationship with industry to disclose relative to the content of this CME activity.

Accreditation: The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The Duke University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)ä.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Unapproved Use Disclosure: Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty at this symposium may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. You must text the six letter code provided by the speaker to (919)213-8033 to receive credit for attending this conference.